306 related articles for article (PubMed ID: 23499826)
1. Estrogen facilitates osteoblast differentiation by upregulating bone morphogenetic protein-4 signaling.
Matsumoto Y; Otsuka F; Takano-Narazaki M; Katsuyama T; Nakamura E; Tsukamoto N; Inagaki K; Sada KE; Makino H
Steroids; 2013 May; 78(5):513-20. PubMed ID: 23499826
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
3. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
7. Acerogenin A, a natural compound isolated from Acer nikoense Maxim, stimulates osteoblast differentiation through bone morphogenetic protein action.
Kihara T; Ichikawa S; Yonezawa T; Lee JW; Akihisa T; Woo JT; Michi Y; Amagasa T; Yamaguchi A
Biochem Biophys Res Commun; 2011 Mar; 406(2):211-7. PubMed ID: 21303661
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T
J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340
[TBL] [Abstract][Full Text] [Related]
10. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
Li J; Hao L; Wu J; Zhang J; Su J
Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh1 induces mouse osteoblast growth and differentiation through the bone morphogenetic protein 2/runt-related gene 2 signalling pathway.
Siddiqi MH; Siddiqi MZ; Ahn S; Kim YJ; Yang DC
J Pharm Pharmacol; 2014 Dec; 66(12):1763-73. PubMed ID: 25154440
[TBL] [Abstract][Full Text] [Related]
13. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells.
Petryk A; Shimmi O; Jia X; Carlson AE; Tervonen L; Jarcho MP; O'connor MB; Gopalakrishnan R
Bone; 2005 Apr; 36(4):617-26. PubMed ID: 15780974
[TBL] [Abstract][Full Text] [Related]
14. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
16. Osterix is required for Sonic hedgehog-induced osteoblastic MC3T3-E1 cell differentiation.
Tian Y; Xu Y; Fu Q; Dong Y
Cell Biochem Biophys; 2012 Dec; 64(3):169-76. PubMed ID: 22648388
[TBL] [Abstract][Full Text] [Related]
17. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2012 Feb; 676(1-3):26-33. PubMed ID: 22192930
[TBL] [Abstract][Full Text] [Related]
18. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
19. KMUP-1 Promotes Osteoblast Differentiation Through cAMP and cGMP Pathways and Signaling of BMP-2/Smad1/5/8 and Wnt/β-Catenin.
Liou SF; Hsu JH; Chu HC; Lin HH; Chen IJ; Yeh JL
J Cell Physiol; 2015 Sep; 230(9):2038-48. PubMed ID: 25536014
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adenosine monophosphate-activated protein kinase suppresses bone morphogenetic protein-2-induced mineralization of osteoblasts via Smad-independent mechanisms.
Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
Endocr J; 2018 Mar; 65(3):291-298. PubMed ID: 29249772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
